It's the question on everyone's mind right now.
Is Carl Icahn's massive bullish position in Herbalife disclosed Thursday just a personal vendetta against Bill Ackman, who is enormously short the vitamin marketing company, or is it a legitimate bullish bet by the billionaire investor?
Icahn's vitriol lobbed at Ackman in a direct fight on CNBC last month would suggest it is just personal, as the veteran activist shouted at the Pershing Square founder that he was a "crybaby" (in reference to a decade-old legal dispute).
However, digging deeper into yesterday's filing, one finds that Icahn's position is largely made up of options, a leveraged bet that suggests that the Wall Street titan may really mean business.



